FOX04-DRI 2mg

Research Context:

A targeted senolytic peptide studied for its ability to selectively induce apoptosis in senescent cells, widely investigated for its potential role in cellular rejuvenation, healthy aging, and tissue function research.

Quality & Testing:

• Purity: 99.70%
  (Verified via HPLC)

• Testing Status: Independent Third-Party Tested

• View Certificate of Analysis (COA)